The Emerging Roles of Nanocarrier Drug Delivery System in Treatment of Intervertebral Disc Degeneration-Current Knowledge, Hot Spots, Challenges and Future Perspectives

References

• Knezevic NN, Candido KD, Vlaeyen JWS, Van Zundert J, Cohen SP. Low back pain. Lancet. 2021;398(10294):78–92. doi:10.1016/S0140-6736(21)00733-9
   PubMed Web of Science ®Google Scholar
• Yu P, Mao F, Chen J, et al. Characteristics and mechanisms of resorption in lumbar disc herniation. Arthritis Res Ther. 2022;24(1):205. doi:10.1186/s13075-022-02894-8
   PubMed Web of Science ®Google Scholar
• Ma K, Chen S, Li Z, et al. Mechanisms of endogenous repair failure during intervertebral disc degeneration. Osteoarthritis Cartilage. 2019;27(1):41–48. doi:10.1016/j.joca.2018.08.021
   PubMed Web of Science ®Google Scholar
• Maher C, Underwood M, Buchbinder R. Non-specific low back pain. Lancet. 2017;389(10070):736–747. doi:10.1016/S0140-6736(16)30970-9
   PubMed Web of Science ®Google Scholar
• Kirnaz S, Capadona C, Wong T, et al. Fundamentals of Intervertebral Disc Degeneration. World Neurosurg. 2022;157:264–273. doi:10.1016/j.wneu.2021.09.066
   PubMed Web of Science ®Google Scholar
• Francisco V, Pino J, González-Gay M, et al. A new immunometabolic perspective of intervertebral disc degeneration. Nat Rev Rheumatol. 2022;18(1):47–60. doi:10.1038/s41584-021-00713-z
   PubMed Web of Science ®Google Scholar
• Wang F, Cai F, Shi R, Wang XH, Wu XT. Aging and age related stresses: a senescence mechanism of intervertebral disc degeneration. Osteoarthritis Cartilage. 2016;24(3):398–408. doi:10.1016/j.joca.2015.09.019
   PubMed Web of Science ®Google Scholar
• Wu PH, Kim HS, Jang IT. Intervertebral disc diseases PART 2: a review of the current diagnostic and treatment strategies for intervertebral disc disease. Int J Mol Sci. 2020;21:6.
   Web of Science ®Google Scholar
• Krut Z, Pelled G, Gazit D, Gazit Z. Stem cells and exosomes: new therapies for intervertebral disc degeneration. Cells. 2021;10(9):2241. doi:10.3390/cells10092241
   PubMed Web of Science ®Google Scholar
• Xin J, Wang Y, Zheng Z, Wang S, Na S, Zhang S. Treatment of Intervertebral Disc Degeneration. Orthop Surg. 2022;14(7):1271–1280. doi:10.1111/os.13254
   PubMed Web of Science ®Google Scholar
• Liang H, Luo R, Li G, Zhang W, Song Y, Yang C. The proteolysis of ECM in intervertebral disc degeneration. Int J Mol Sci. 2022;23:3.
   Web of Science ®Google Scholar
• Alrwaily M, Timko M, Schneider M, et al. Treatment-based classification system for low back pain: revision and update. Phys Ther. 2016;96(7):1057–1066. doi:10.2522/ptj.20150345
   PubMed Web of Science ®Google Scholar
• Corp N, Mansell G, Stynes S, et al. Evidence-based treatment recommendations for neck and low back pain across Europe: a systematic review of guidelines. Eur J Pain. 2021;25(2):275–295. doi:10.1002/ejp.1679
   PubMed Web of Science ®Google Scholar
• Flotte TR. Epigenome editing strategies for low back pain. Hum Gene Ther. 2019;30(9):1037–1038. doi:10.1089/hum.2019.29094.trf
   PubMed Web of Science ®Google Scholar
• Richardson SM, Kalamegam G, Pushparaj PN, et al. Mesenchymal stem cells in regenerative medicine: focus on articular cartilage and intervertebral disc regeneration. Methods. 2016;99:69–80. doi:10.1016/j.ymeth.2015.09.015
   PubMed Web of Science ®Google Scholar
• Urits I, Capuco A, Sharma M, et al. Stem cell therapies for treatment of discogenic low back pain: a comprehensive review. Curr Pain Headache Rep. 2019;23(9):65. doi:10.1007/s11916-019-0804-y
   PubMed Web of Science ®Google Scholar
• Shi P, Cheng Z, Zhao K, et al. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. J Nanobiotechnology. 2023;21(1):103. doi:10.1186/s12951-023-01826-1
   PubMed Web of Science ®Google Scholar
• Lv Y, Li W, Liao W, et al. Nano-drug delivery systems based on natural products. Int J Nanomed. 2024;19:541–569. doi:10.2147/IJN.S443692
   PubMed Web of Science ®Google Scholar
• Das UN. Bioactive lipids in intervertebral disc degeneration and its therapeutic implications. Biosci Rep. 2019;39(10). doi:10.1042/BSR20192117
   PubMedGoogle Scholar
• Sun J, Yang F, Wang L, et al. Delivery of coenzyme Q10 loaded micelle targets mitochondrial ROS and enhances efficiency of mesenchymal stem cell therapy in intervertebral disc degeneration. Bioact Mater. 2023;23:247–260. doi:10.1016/j.bioactmat.2022.10.019
   PubMed Web of Science ®Google Scholar
• Li J, Duan W, Chai S, et al. Wogonin, a bioactive ingredient from huangqi guizhi formula, alleviates discogenic low back pain via suppressing the overexpressed NGF in intervertebral discs. Mediators Inflamm. 2023;2023:4436587. doi:10.1155/2023/4436587
   PubMed Web of Science ®Google Scholar
• Guo T, Zhang X, Hu Y, et al. New hope for treating intervertebral disc degeneration: microsphere-based delivery system. Front Bioeng Biotechnol. 2022;10:933901. doi:10.3389/fbioe.2022.933901
   PubMed Web of Science ®Google Scholar
• Wu R, Huang L, Xia Q, et al. Injectable mesoporous bioactive glass/sodium alginate hydrogel loaded with melatonin for intervertebral disc regeneration. Mater Today Bio. 2023;22:100731. doi:10.1016/j.mtbio.2023.100731
   PubMedGoogle Scholar
• Vergroesen PP, Kingma I, Emanuel KS, et al. Mechanics and biology in intervertebral disc degeneration: a vicious circle. Osteoarthritis Cartilage. 2015;23(7):1057–1070. doi:10.1016/j.joca.2015.03.028
   PubMed Web of Science ®Google Scholar
• Iatridis JC, Nicoll SB, Michalek AJ, Walter BA, Gupta MS. Role of biomechanics in intervertebral disc degeneration and regenerative therapies: what needs repairing in the disc and what are promising biomaterials for its repair? Spine J. 2013;13(3):243–262. doi:10.1016/j.spinee.2012.12.002
   PubMed Web of Science ®Google Scholar
• Calderon L, Collin E, Velasco-Bayon D, Murphy M, O’Halloran D, Pandit A. Type II collagen-hyaluronan hydrogel--a step towards a scaffold for intervertebral disc tissue engineering. Eur Cell Mater. 2010;20:134–148. doi:10.22203/eCM.v020a12
   PubMed Web of Science ®Google Scholar
• Zhou X, Shen N, Tao Y, et al. Nucleus pulposus cell-derived efficient microcarrier for intervertebral disc tissue engineering. Biofabrication. 2023;15(2):025008. doi:10.1088/1758-5090/acb572
   Web of Science ®Google Scholar
• Brissenden AJ, Amsden BG. In situ forming macroporous biohybrid hydrogel for nucleus pulposus cell delivery. Acta Biomater. 2023;170:169–184. doi:10.1016/j.actbio.2023.08.029
   PubMed Web of Science ®Google Scholar
• Liang T, Zhang LL, Xia W, Yang HL, Luo ZP. Individual collagen fibril thickening and stiffening of annulus fibrosus in degenerative intervertebral disc. Spine. 2017;42(19):E1104–E1111. doi:10.1097/BRS.0000000000002085
   PubMed Web of Science ®Google Scholar
• Tromp IN, Foolen J, van Doeselaar M, et al. Comparison of annulus fibrosus cell collagen remodeling rates in a microtissue system. J Orthop Res. 2021;39(9):1955–1964. doi:10.1002/jor.24921
   PubMed Web of Science ®Google Scholar
• Moriguchi Y, Borde B, Berlin C, et al. In vivo annular repair using high-density collagen gel seeded with annulus fibrosus cells. Acta Biomater. 2018;79:230–238. doi:10.1016/j.actbio.2018.07.008
   PubMed Web of Science ®Google Scholar
• Wang Y, Videman T, Battié MC. Lumbar vertebral endplate lesions: prevalence, classification, and association with age. Spine. 2012;37(17):1432–1439. doi:10.1097/BRS.0b013e31824dd20a
   PubMed Web of Science ®Google Scholar
• Fontana G, See E, Pandit A. Current trends in biologics delivery to restore intervertebral disc anabolism. Adv Drug Deliv Rev. 2015;84:146–158. doi:10.1016/j.addr.2014.08.008
   PubMed Web of Science ®Google Scholar
• Boyd LM, Carter AJ. Injectable biomaterials and vertebral endplate treatment for repair and regeneration of the intervertebral disc. Eur Spine J. 2006;15(Suppl 3):S414–421. doi:10.1007/s00586-006-0172-2
   PubMedGoogle Scholar
• Sun Q, Tian FM, Liu F, et al. Denosumab alleviates intervertebral disc degeneration adjacent to lumbar fusion by inhibiting endplate osteochondral remodeling and vertebral osteoporosis in ovariectomized rats. Arthritis Res Ther. 2021;23(1):152. doi:10.1186/s13075-021-02525-8
   PubMed Web of Science ®Google Scholar
• Ding WY, Yang DL, Cao LZ, et al. Intervertebral disc degeneration and bone density in degenerative lumbar scoliosis: a comparative study between patients with degenerative lumbar scoliosis and patients with lumbar stenosis. Chin Med J. 2011;124(23):3875–3878.
   PubMed Web of Science ®Google Scholar
• Roh EJ, Darai A, Kyung JW, et al. Genetic therapy for intervertebral disc degeneration. Int J Mol Sci. 2021;22(4):1579. doi:10.3390/ijms22041579
   PubMed Web of Science ®Google Scholar
• Kreiner DS, Hwang SW, Easa JE, et al. An evidence-based clinical guideline for the diagnosis and treatment of lumbar disc herniation with radiculopathy. Spine J. 2014;14(1):180–191. doi:10.1016/j.spinee.2013.08.003
   PubMed Web of Science ®Google Scholar
• van der Windt DA, Simons E, Riphagen II, et al. Physical examination for lumbar radiculopathy due to disc herniation in patients with low-back pain. Cochrane Database Syst Rev. 2010;2:Cd007431.
   PubMed Web of Science ®Google Scholar
• Tao S, Jin L, Hou Z, Zhang W, Chen T, Zhang Y. A New radiographic feature of lower lumbar disc herniation in young patients. Int Orthop. 2018;42(3):583–586. doi:10.1007/s00264-017-3723-8
   PubMed Web of Science ®Google Scholar
• Kim JH, van Rijn RM, van Tulder MW, et al. Diagnostic accuracy of diagnostic imaging for lumbar disc herniation in adults with low back pain or sciatica is unknown; a systematic review. Chiropr Man Therap. 2018;26:37. doi:10.1186/s12998-018-0207-x
   PubMed Web of Science ®Google Scholar
• Zheng K, Wen Z, Li D. The clinical diagnostic value of lumbar intervertebral disc herniation based on MRI images. J Healthc Eng. 2021;2021:5594920. doi:10.1155/2021/5594920
   PubMed Web of Science ®Google Scholar
• Jackson RP, Becker GJ, Jacobs RR, Montesano PX, Cooper BR, McManus GE. The neuroradiographic diagnosis of lumbar herniated nucleus pulposus: i. A comparison of computed tomography (CT), myelography, CT-myelography, discography, and CT-discography. Spine. 1989;14(12):1356–1361. doi:10.1097/00007632-198912000-00012
   PubMed Web of Science ®Google Scholar
• Pinto M, Mehbod AA, Swanberg BA, Dawson JM, Schellhas K. Provocative discography: diagnostic efficacy and safety in symptomatic degenerative disk disease. Clin Spine Surg. 2022;35(7):E571–E575. doi:10.1097/BSD.0000000000001329
   PubMed Web of Science ®Google Scholar
• Morita M, Miyauchi A, Okuda S, Oda T, Iwasaki M. Electrophysiological study for nerve root entrapment in patients with isthmic spondylolisthesis. Clin Spine Surg. 2017;30(3):E198–E204. doi:10.1097/BSD.0000000000000047
   PubMed Web of Science ®Google Scholar
• Yildirim P, Gultekin A. The effect of a stretch and strength-based yoga exercise program on patients with neuropathic pain due to lumbar disc herniation. Spine. 2022;47(10):711–719. doi:10.1097/BRS.0000000000004316
   PubMed Web of Science ®Google Scholar
• Zhang B, Xu H, Wang J, Liu B, Sun G. A narrative review of non-operative treatment, especially traditional Chinese medicine therapy, for lumbar intervertebral disc herniation. Biosci Trends. 2017;11(4):406–417. doi:10.5582/bst.2017.01199
   PubMed Web of Science ®Google Scholar
• Awadalla AM, Aljulayfi AS, Alrowaili AR, et al. Management of lumbar disc herniation: a systematic review. Cureus. 2023;15:10.
   Web of Science ®Google Scholar
• Nerubay J, Caspi I, Levinkopf M, Tadmor A, Bubis JJ. Percutaneous laser nucleolysis of the intervertebral lumbar disc. An experimental study. Clin Orthop Relat Res. 1997;337:42–44. doi:10.1097/00003086-199704000-00005
   Google Scholar
• Grangeat AM, Erario MLA. The use of medical ozone in chronic intervertebral disc degeneration can be an etiological and conservative treatment. Int J Mol Sci. 2023;24(7):6538. doi:10.3390/ijms24076538
   PubMed Web of Science ®Google Scholar
• He J, Xiao S, Wu Z, Yuan Z. Microendoscopic discectomy versus open discectomy for lumbar disc herniation: a meta-analysis. Eur Spine J. 2016;25(5):1373–1381. doi:10.1007/s00586-016-4523-3
   PubMed Web of Science ®Google Scholar
• Pan M, Li Q, Li S, et al. Percutaneous Endoscopic Lumbar Discectomy: indications and Complications. Pain Physician. 2020;23(1):49–56.
   PubMed Web of Science ®Google Scholar
• Chu PL, Wang T, Zheng JL, et al. Global and current research trends of unilateral biportal endoscopy/biportal endoscopic spinal surgery in the treatment of lumbar degenerative diseases: a bibliometric and visualization study. Orthop Surg. 2022;14(4):635–643. doi:10.1111/os.13216
   PubMed Web of Science ®Google Scholar
• Mobbs RJ, Phan K, Malham G, Seex K, Rao PJ. Lumbar interbody fusion: techniques, indications and comparison of interbody fusion options including PLIF, TLIF, MI-TLIF, OLIF/ATP, LLIF and ALIF. J Spine Surg. 2015;1(1):2–18. doi:10.3978/j.issn.2414-469X.2015.10.05
   PubMedGoogle Scholar
• Lamartina C, Berjano P. Prone single-position extreme lateral interbody fusion (Pro-XLIF): preliminary results. Eur Spine J. 2020;29(Suppl 1):6–13. doi:10.1007/s00586-020-06303-z
   PubMed Web of Science ®Google Scholar
• Meyer SA, Mummaneni PV. Axial interbody fusion. J Neurosurg Spine. 2011;15(3):271. doi:10.3171/2011.1.SPINE10913
   PubMed Web of Science ®Google Scholar
• Franco D, Largoza G, Montenegro TS, Gonzalez GA, Hines K, Harrop J. Lumbar total disc replacement: current usage. Neurosurg Clin N Am. 2021;32(4):511–519. doi:10.1016/j.nec.2021.05.010
   PubMed Web of Science ®Google Scholar
• Colella F, Garcia JP, Sorbona M, et al. Drug delivery in intervertebral disc degeneration and osteoarthritis: selecting the optimal platform for the delivery of disease-modifying agents. J Control Release. 2020;328:985–999. doi:10.1016/j.jconrel.2020.08.041
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Liu W, Ma Z, Wang Y, Yang J. Multiple nano-drug delivery systems for intervertebral disc degeneration: current status and future perspectives. Bioact Mater. 2023;23:274–299. doi:10.1016/j.bioactmat.2022.11.006
   PubMed Web of Science ®Google Scholar
• Liang C, Li H, Li C, et al. Fabrication of a layered microstructured polymeric microspheres as a cell carrier for nucleus pulposus regeneration. J Biomater Sci Polym Ed. 2012;23(18):2287–2302. doi:10.1163/156856211X614789
   PubMed Web of Science ®Google Scholar
• Frapin L, Clouet J, Delplace V, Fusellier M, Guicheux J, Le Visage C. Lessons learned from intervertebral disc pathophysiology to guide rational design of sequential delivery systems for therapeutic biological factors. Adv Drug Deliv Rev. 2019;149-150:49–71. doi:10.1016/j.addr.2019.08.007
   PubMed Web of Science ®Google Scholar
• Zhu L, Yang Y, Yan Z, et al. Controlled release of TGF-β3 for effective local endogenous repair in IDD using rat model. Int J Nanomed. 2022;17:2079–2096. doi:10.2147/IJN.S358396
   PubMed Web of Science ®Google Scholar
• Adepu S, Ramakrishna S. Controlled drug delivery systems: current status and future directions. Molecules. 2021;26(19):5905. doi:10.3390/molecules26195905
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiao J, Niu M, et al. Ten years of knowledge of nano-carrier based drug delivery systems in ophthalmology: current evidence, challenges, and future prospective. Int J Nanomed. 2021;16:6497–6530. doi:10.2147/IJN.S329831
   PubMed Web of Science ®Google Scholar
• Zhou D, Zhou F, Sheng S, Wei Y, Chen X, Su J. Intra-articular nanodrug delivery strategies for treating osteoarthritis. Drug Discov Today. 2023;28(3):103482. doi:10.1016/j.drudis.2022.103482
   PubMed Web of Science ®Google Scholar
• Hang Y, Liu Y, Teng Z, Cao X, Zhu H. Mesoporous nanodrug delivery system: a powerful tool for a new paradigm of remodeling of the tumor microenvironment. J Nanobiotechnology. 2023;21(1):101. doi:10.1186/s12951-023-01841-2
   PubMed Web of Science ®Google Scholar
• Li B, Shao H, Gao L, Li H, Sheng H, Zhu L. Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review. Drug Deliv. 2022;29(1):2130–2161. doi:10.1080/10717544.2022.2094498
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.037
   PubMed Web of Science ®Google Scholar
• Sarfraz M, Afzal A, Yang T, et al. Development of dual drug loaded nanosized liposomal formulation by a reengineered ethanolic injection method and its pre-clinical pharmacokinetic studies. Pharmaceutics. 2018;10(3):151. doi:10.3390/pharmaceutics10030151
   PubMed Web of Science ®Google Scholar
• Manshian BB, Jiménez J, Himmelreich U, Soenen SJ. Personalized medicine and follow-up of therapeutic delivery through exploitation of quantum dot toxicity. Biomaterials. 2017;127:1–12. doi:10.1016/j.biomaterials.2017.02.039
   PubMed Web of Science ®Google Scholar
• Arias LS, Pessan JP, Vieira APM, Lima TMT, Delbem ACB, Monteiro DR. Iron oxide nanoparticles for biomedical applications: a perspective on synthesis, drugs, antimicrobial activity, and toxicity. Antibiotics. 2018;7(2). doi:10.3390/antibiotics7020046
   Google Scholar
• Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–124. doi:10.1038/s41573-020-0090-8
   PubMed Web of Science ®Google Scholar
• Zhang H, Yu S, Zhao X, Mao Z, Gao C. Stromal cell-derived factor-1α-encapsulated albumin/heparin nanoparticles for induced stem cell migration and intervertebral disc regeneration in vivo. Acta Biomater. 2018;72:217–227. doi:10.1016/j.actbio.2018.03.032
   PubMed Web of Science ®Google Scholar
• Ahlawat J, Henriquez G, Narayan M. Enhancing the delivery of chemotherapeutics: role of biodegradable polymeric nanoparticles. Molecules. 2018;23(9):2157. doi:10.3390/molecules23092157
   PubMed Web of Science ®Google Scholar
• Singh A, Rath G, Singh R, Goyal AK. Nanofibers: an effective tool for controlled and sustained drug delivery. Curr Drug Deliv. 2018;15(2):155–166. doi:10.2174/1567201814666171002115230
   PubMed Web of Science ®Google Scholar
• Haidar MK, Eroglu H. Nanofibers: new Insights for Drug Delivery and Tissue Engineering. Curr Top Med Chem. 2017;17(13):1564–1579. doi:10.2174/1568026616666161222102641
   PubMed Web of Science ®Google Scholar
• Aranda-Lara L, García BEO, Isaac-Olivé K, Ferro-Flores G, Meléndez-Alafort L, Morales-Avila E. Drug delivery systems-based dendrimers and polymer micelles for nuclear diagnosis and therapy. Macromol Biosci. 2021;21(3):e2000362. doi:10.1002/mabi.202000362
   PubMed Web of Science ®Google Scholar
• de Prinse M, Qi R, Amsden BG. Polymer micelles for the protection and delivery of specialized pro-resolving mediators. Eur J Pharm Biopharm. 2023;184:159–169. doi:10.1016/j.ejpb.2023.01.020
   PubMed Web of Science ®Google Scholar
• Vinogradov SV. Nanogels in the race for drug delivery. Nanomedicine. 2010;5(2):165–168. doi:10.2217/nnm.09.103
   PubMed Web of Science ®Google Scholar
• Pan Y, Li Y, Dong W, Jiang B, Yu Y, Chen Y. Role of nano-hydrogels coated exosomes in bone tissue repair. Front Bioeng Biotechnol. 2023;11:1167012. doi:10.3389/fbioe.2023.1167012
   PubMed Web of Science ®Google Scholar
• Zou J, Yang W, Cui W, et al. Therapeutic potential and mechanisms of mesenchymal stem cell-derived exosomes as bioactive materials in tendon-bone healing. J Nanobiotechnology. 2023;21(1):14. doi:10.1186/s12951-023-01778-6
   PubMed Web of Science ®Google Scholar
• Shahabipour F, Banach M, Sahebkar A. Exosomes as nanocarriers for siRNA delivery: paradigms and challenges. Arch Med Sci. 2016;12(6):1324–1326. doi:10.5114/aoms.2016.62911
   PubMed Web of Science ®Google Scholar
• Mondal J, Pillarisetti S, Junnuthula V, et al. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications. J Control Release. 2023;353:1127–1149. doi:10.1016/j.jconrel.2022.12.027
   PubMed Web of Science ®Google Scholar
• Li T, Takeoka S. A novel application of maleimide for advanced drug delivery: in vitro and in vivo evaluation of maleimide-modified pH-sensitive liposomes. Int J Nanomed. 2013;8:3855–3866. doi:10.2147/IJN.S47749
   PubMed Web of Science ®Google Scholar
• Banala RR, Vemuri SK, Dar GH, et al. Efficiency of dual siRNA-mediated gene therapy for intervertebral disc degeneration (IVDD). Spine J. 2019;19(5):896–904. doi:10.1016/j.spinee.2018.10.016
   PubMed Web of Science ®Google Scholar
• Wang H, Ding Y, Zhang W, et al. Oxymatrine liposomes for intervertebral disc treatment: formulation, in vitro and vivo assessments. Drug Des Devel Ther. 2020;14:921–931. doi:10.2147/DDDT.S242493
   PubMed Web of Science ®Google Scholar
• Ma X, Luan Z, Li J. Inorganic nanoparticles-based systems in biomedical applications of stem cells: opportunities and challenges. Int J Nanomed. 2023;18:143–182. doi:10.2147/IJN.S384343
   PubMed Web of Science ®Google Scholar
• Zhou T, Yang X, Chen Z, et al. Prussian blue nanoparticles stabilize SOD1 from ubiquitination-proteasome degradation to rescue intervertebral disc degeneration. Adv Sci. 2022;9(10):e2105466.
   Web of Science ®Google Scholar
• Tng DJ, Song P, Lin G, et al. Synthesis and characterization of multifunctional hybrid-polymeric nanoparticles for drug delivery and multimodal imaging of cancer. Int J Nanomed. 2015;10:5771–5786. doi:10.2147/IJN.S86468
   PubMed Web of Science ®Google Scholar
• Lim S, An SB, Jung M, et al. Local delivery of senolytic drug inhibits intervertebral disc degeneration and restores intervertebral disc structure. Adv Healthc Mater. 2022;11(2):e2101483. doi:10.1002/adhm.202101483
   PubMed Web of Science ®Google Scholar
• Arul MR, Zhang C, Alahmadi I, et al. Novel injectable fluorescent polymeric nanocarriers for intervertebral disc application. J Funct Biomater. 2023;14(2):52. doi:10.3390/jfb14020052
   PubMed Web of Science ®Google Scholar
• Kralovic M, Vjaclovsky M, Tonar Z, et al. Nanofiber fractionalization stimulates healing of large intestine anastomoses in rabbits. Int J Nanomed. 2022;17:6335–6345. doi:10.2147/IJN.S364888
   PubMed Web of Science ®Google Scholar
• Yu Q, Han F, Yuan Z, et al. Fucoidan-loaded nanofibrous scaffolds promote annulus fibrosus repair by ameliorating the inflammatory and oxidative microenvironments in degenerative intervertebral discs. Acta Biomater. 2022;148:73–89. doi:10.1016/j.actbio.2022.05.054
   PubMed Web of Science ®Google Scholar
• Tu Z, Han F, Zhu Z, et al. Sustained release of basic fibroblast growth factor in micro/nanofibrous scaffolds promotes annulus fibrosus regeneration. Acta Biomater. 2023;166:241–253. doi:10.1016/j.actbio.2023.05.034
   PubMed Web of Science ®Google Scholar
• Yang Y, Li Y, Chen K, et al. Dual Receptor-targeted and redox-sensitive polymeric micelles self-assembled from a folic acid-hyaluronic Acid-SS-Vitamin E Succinate polymer for precise cancer therapy. Int J Nanomed. 2020;15:2885–2902. doi:10.2147/IJN.S249205
   PubMed Web of Science ®Google Scholar
• Yu C, Li D, Wang C, et al. Injectable kartogenin and apocynin loaded micelle enhances the alleviation of intervertebral disc degeneration by adipose-derived stem cell. Bioact Mater. 2021;6(10):3568–3579. doi:10.1016/j.bioactmat.2021.03.018
   PubMed Web of Science ®Google Scholar
• Chang CC, Tsou HK, Chang HH, et al. Runx1 messenger RNA delivered by polyplex nanomicelles alleviate spinal disc hydration loss in a rat disc degeneration model. Int J Mol Sci. 2022;23(1).
   Web of Science ®Google Scholar
• Quazi MZ, Park N. Nanohydrogels: advanced polymeric nanomaterials in the era of nanotechnology for robust functionalization and cumulative applications. Int J Mol Sci. 2022;23(4):1943. doi:10.3390/ijms23041943
   PubMed Web of Science ®Google Scholar
• Chang H, Cai F, Zhang Y, et al. Silencing gene-engineered injectable hydrogel microsphere for regulation of extracellular matrix metabolism balance. Small Methods. 2022;6:4.
   Web of Science ®Google Scholar
• Luo H, Wang Z, He Z, et al. Injectable chondroitin sulfate-grafted self-antioxidant hydrogels ameliorate nucleus pulposus degeneration against overactive inflammation. Biomater Sci. 2023;11(10):3629–3644. doi:10.1039/D3BM00359K
   PubMed Web of Science ®Google Scholar
• Gurunathan S, Kang MH, Kim JH. A comprehensive review on factors influences biogenesis, functions, therapeutic and clinical implications of exosomes. Int J Nanomed. 2021;16:1281–1312. doi:10.2147/IJN.S291956
   PubMed Web of Science ®Google Scholar
• Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021;11(7):3183–3195. doi:10.7150/thno.52570
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Liu H, Tang WH. Exosomes: biogenesis, biologic function and clinical potential. Cell Biosci. 2019;9:19. doi:10.1186/s13578-019-0282-2
   PubMed Web of Science ®Google Scholar
• Zhu L, Shi Y, Liu L, Wang H, Shen P, Yang H. Mesenchymal stem cells-derived exosomes ameliorate nucleus pulposus cells apoptosis via delivering miR-142-3p: therapeutic potential for intervertebral disc degenerative diseases. Cell Cycle. 2020;19(14):1727–1739. doi:10.1080/15384101.2020.1769301
   PubMed Web of Science ®Google Scholar
• Sun Z, Tang X, Li Q, Wang H, Sun H, Tian J. Mesenchymal stem cell extracellular vesicles-derived microRNA-194-5p delays the development of intervertebral disc degeneration by targeting TRAF6. Regen Ther. 2022;19:88–96. doi:10.1016/j.reth.2021.12.001
   PubMed Web of Science ®Google Scholar
• Sun Y, Zhang W, Li X. Induced pluripotent stem cell-derived mesenchymal stem cells deliver exogenous miR-105-5p via small extracellular vesicles to rejuvenate senescent nucleus pulposus cells and attenuate intervertebral disc degeneration. Stem Cell Res Ther. 2021;12(1):286. doi:10.1186/s13287-021-02362-1
   PubMed Web of Science ®Google Scholar
• Zhu G, Yang X, Peng C, Yu L, Hao Y. Exosomal miR-532-5p from bone marrow mesenchymal stem cells reduce intervertebral disc degeneration by targeting RASSF5. Exp Cell Res. 2020;393(2):112109. doi:10.1016/j.yexcr.2020.112109
   PubMed Web of Science ®Google Scholar
• Cui S, Zhang L. microRNA-129-5p shuttled by mesenchymal stem cell-derived extracellular vesicles alleviates intervertebral disc degeneration via blockade of LRG1-mediated p38 MAPK activation. J Tissue Eng. 2021;12:20417314211021679. doi:10.1177/20417314211021679
   Web of Science ®Google Scholar
• Sun Z, Liu B, Liu ZH, et al. Notochordal-cell-derived exosomes induced by compressive load inhibit angiogenesis via the miR-140-5p/Wnt/β-Catenin Axis. Mol Ther Nucleic Acids. 2020;22:1092–1106. doi:10.1016/j.omtn.2020.10.021
   PubMedGoogle Scholar
• Zhou ZM, Bao JP, Peng X, et al. Small extracellular vesicles from hypoxic mesenchymal stem cells alleviate intervertebral disc degeneration by delivering miR-17-5p. Acta Biomater. 2022;140:641–658. doi:10.1016/j.actbio.2021.11.044
   PubMed Web of Science ®Google Scholar
• Chen D, Jiang X, Zou H. hASCs-derived exosomal miR-155-5p targeting TGFβR2 promotes autophagy and reduces pyroptosis to alleviate intervertebral disc degeneration. J Orthop Translat. 2023;39:163–176. doi:10.1016/j.jot.2023.02.004
   PubMed Web of Science ®Google Scholar
• Zhao X, Sun Z, Xu B, et al. Degenerated nucleus pulposus cells derived exosome carrying miR-27a-3p aggravates intervertebral disc degeneration by inducing M1 polarization of macrophages. J Nanobiotechnology. 2023;21(1):317. doi:10.1186/s12951-023-02075-y
   PubMed Web of Science ®Google Scholar
• Zhang H, Wu J, Wu J, et al. Exosome-mediated targeted delivery of miR-210 for angiogenic therapy after cerebral ischemia in mice. J Nanobiotechnology. 2019;17(1):29. doi:10.1186/s12951-019-0461-7
   PubMedGoogle Scholar
• Jia G, Han Y, An Y, et al. NRP-1 targeted and cargo-loaded exosomes facilitate simultaneous imaging and therapy of glioma in vitro and in vivo. Biomaterials. 2018;178:302–316. doi:10.1016/j.biomaterials.2018.06.029
   PubMed Web of Science ®Google Scholar
• Kooijmans SA, Aleza CG, Roffler SR, van Solinge WW, Vader P, Schiffelers RM. Display of GPI-anchored anti-EGFR nanobodies on extracellular vesicles promotes tumour cell targeting. J Extracell Vesicles. 2016;5:31053. doi:10.3402/jev.v5.31053
   PubMed Web of Science ®Google Scholar
• Tian T, Cao L, He C, et al. Targeted delivery of neural progenitor cell-derived extracellular vesicles for anti-inflammation after cerebral ischemia. Theranostics. 2021;11(13):6507–6521. doi:10.7150/thno.56367
   PubMed Web of Science ®Google Scholar
• Villata S, Canta M, Cauda V. EVs and Bioengineering: from Cellular Products to Engineered Nanomachines. Int J Mol Sci. 2020;21(17). doi:10.3390/ijms21176048
   PubMed Web of Science ®Google Scholar
• Poongodi R, Chen YL, Yang TH, et al. Bio-scaffolds as cell or exosome carriers for nerve injury repair. Int J Mol Sci. 2021;22(24). doi:10.3390/ijms222413347
   PubMed Web of Science ®Google Scholar
• Zou Z, Li H, Xu G, Hu Y, Zhang W, Tian K. Current knowledge and future perspectives of exosomes as nanocarriers in diagnosis and treatment of diseases. Int J Nanomed. 2023;18:4751–4778. doi:10.2147/IJN.S417422
   PubMed Web of Science ®Google Scholar
• Zhang Y, Huo M, Wang Y, et al. A tailored bioactive 3D porous poly(lactic-acid)-exosome scaffold with osteo-immunomodulatory and osteogenic differentiation properties. J Biol Eng. 2022;16(1):22. doi:10.1186/s13036-022-00301-z
   PubMed Web of Science ®Google Scholar
• Mi S, Chang Z, Wang X, et al. Bioactive spinal cord scaffold releasing neurotrophic exosomes to promote in situ centralis neuroplasticity. ACS Appl Mater Interfaces. 2023;15(13):16355–16368. doi:10.1021/acsami.2c19607
   PubMed Web of Science ®Google Scholar
• Zhang M, Xiao B, Wang H, et al. Edible ginger-derived nano-lipids loaded with doxorubicin as a novel drug-delivery approach for colon cancer therapy. Mol Ther. 2016;24(10):1783–1796. doi:10.1038/mt.2016.159
   PubMed Web of Science ®Google Scholar
• Liu B, Lu Y, Chen X, et al. Protective role of shiitake mushroom-derived exosome-like nanoparticles in D-galactosamine and lipopolysaccharide-induced acute liver injury in mice. Nutrients. 2020;12:2.
   Web of Science ®Google Scholar
• Liu H, Gu R, Li W, et al. Engineering 3D-printed strontium-titanium scaffold-integrated highly bioactive serum exosomes for critical bone defects by osteogenesis and angiogenesis. ACS Appl Mater Interfaces. 2023;15(23):27486–27501. doi:10.1021/acsami.3c00898
   PubMed Web of Science ®Google Scholar
• Li Q, Yu H, Zhao F, et al. 3D printing of microenvironment-specific bioinspired and exosome-reinforced hydrogel scaffolds for efficient cartilage and subchondral bone regeneration. Adv Sci. 2023;10(26):e2303650. doi:10.1002/advs.202303650
   Web of Science ®Google Scholar